Patricia
Miranda Azpiazu
Investigadora hasta 2024
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Icahn School of Medicine at Mount Sinai (2)
2016
-
Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia
Science Signaling, Vol. 9, Núm. 410
2014
-
Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment
Neuropharmacology, Vol. 86, pp. 311-318